Escin activates AKT-Nrf2 signaling to protect retinal pigment epithelium cells from oxidative stress.

作者: Kaijun Wang , Yiqian Jiang , Wei Wang , Jian Ma , Min Chen

DOI: 10.1016/J.BBRC.2015.10.117

关键词:

摘要: Here we explored the anti-oxidative and cytoprotective potentials of escin, a natural triterpene-saponin, against hydrogen peroxide (H2O2) in retinal pigment epithelium (RPE) cells. We showed that escin remarkably attenuated H2O2-induced death apoptosis established (ARPE-19) primary murine RPE Meanwhile, ROS production lipid peroxidation by H2O2 were inhibited escin. Escin treatment cells resulted NF-E2-related factor 2 (Nrf2) signaling activation, evidenced transcription anti-oxidant-responsive element (ARE)-regulated genes, including HO-1, NQO-1 SRXN-1. Knockdown Nrf2 through targeted shRNAs/siRNAs alleviated escin-mediated ARE gene transcription, almost abolished anti-oxidant activity cytoprotection H2O2. Reversely, was more potent damages Nrf2-over-expressed ARPE-19 Further studies escin-induced activation required AKT signaling. inhibitors (LY294002 perifosine) blocked dramatically phosphorylation, its cytosol accumulation nuclear translocation Escin-induced also inhibitors. Together, these results demonstrate protects from oxidative stress possibly activating AKT-Nrf2

参考文章(30)
Vašková J, Vaško L, Fejerčáková A, Patlevič P, Mojžišová G, Antioxidant potential of Aesculus hippocastanum extract and escin against reactive oxygen and nitrogen species. European Review for Medical and Pharmacological Sciences. ,vol. 19, pp. 879- 886 ,(2015)
Sven Erik G. Nilsson, Staffan P. Sundelin, Ulf Wihlmark, Ulf T. Brunk, Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage Documenta Ophthalmologica. ,vol. 106, pp. 13- 16 ,(2003) , 10.1023/A:1022419606629
Kati Kinnunen, Goran Petrovski, Morten C. Moe, András Berta, Kai Kaarniranta, Molecular mechanisms of retinal pigment epithelium damage and development of age‐related macular degeneration Acta Ophthalmologica. ,vol. 90, pp. 299- 309 ,(2012) , 10.1111/J.1755-3768.2011.02179.X
Cesare R. Sirtori, Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacological Research. ,vol. 44, pp. 183- 193 ,(2001) , 10.1006/PHRS.2001.0847
Yong-Wei Wang, Shuang-Jia Wang, Yi-Nan Zhou, Shang-Ha Pan, Bei Sun, Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo Journal of Cancer Research and Clinical Oncology. ,vol. 138, pp. 785- 797 ,(2012) , 10.1007/S00432-012-1152-Z
Sarah Crunkhorn, Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress. Nature Reviews Drug Discovery. ,vol. 11, pp. 96- 96 ,(2012) , 10.1038/NRD3655
Ken Itoh, Kit I Tong, Masayuki Yamamoto, Molecular mechanism activating nrf2–keap1 pathway in regulation of adaptive response to electrophiles Free Radical Biology and Medicine. ,vol. 36, pp. 1208- 1213 ,(2004) , 10.1016/J.FREERADBIOMED.2004.02.075
Da-min Gu, Pei-Hua Lu, Ke Zhang, Xiang Wang, Min Sun, Guo-Qian Chen, Qiong Wang, EGFR mediates astragaloside IV-induced Nrf2 activation to protect cortical neurons against in vitro ischemia/reperfusion damages. Biochemical and Biophysical Research Communications. ,vol. 457, pp. 391- 397 ,(2015) , 10.1016/J.BBRC.2015.01.002